Skip to main content
. 2020 Jul 8;12(13):13488–13501. doi: 10.18632/aging.103451

Figure 4.

Figure 4

TRIM29 promotes autophagy in lung squamous cell carcinoma. (A) Western blot analysis of TRIM29, LC3-I, and LC3-II in TRIM29 over-expression treated HTB-182 cells with or without CQ treatment. (B) Western blot analysis of TRIM29 and p62 in TRIM29 over-expression treated HTB-182 cells. (C) The relative account of LC3-II and p62 in TRIM29 over-expression treated HTB-182 cells. (D) confocal analysis of GFP-LC3II expression in TRIM29 over-expression treated HTB-182 with PBS and CQ treatment. (E) The relative GFP-LC3II expression in TRIM29 over-expression treated HTB-182 with or without CQ treatment. (F) Western blot analysis of TRIM29, LC3-I, and LC3-II in TRIM29 knockdown treated NCI-H1915 cells with or without CQ treatment. (G) Western blot analysis of TRIM29 and p62 in TRIM29 knockdown treated NCI-H1915 cells. (H) The relative account of LC3-II and p62 in TRIM29 knockdown treated NCI-H1915 cells. (I) confocal analysis of GFP-LC3II expression in TRIM29 knockdown treated NCI-H1915 cells with PBS and CQ treatment. (J) The relative GFP-LC3II expression in TRIM29 knockdown treated NCI-H1915 cells with or without CQ treatment. **P<0.01.